Henan Dongtai Pharma

Henan Dongtai Pharma is a China-based pharmaceutical manufacturer focused on small-molecule active pharmaceutical ingredients and related intermediates rather than an innovative clinical-stage biotech pipeline. The company was founded in 2002 and operates from Anyang, Henan, with GMP-based manufacturing and export capabilities serving China and international markets. Publicly described core products include diclofenac sodium, diclofenac potassium, aceclofenac, acemetacin, celecoxib, rimantadine hydrochloride, norfloxacin, irinotecan hydrochloride, and topotecan hydrochloride, along with upstream intermediates. The business appears centered on commercial production, regulatory supply, and contract or custom manufacturing support for pharmaceutical customers. Available evidence indicates it is an active private company under Dongtai Holding, with a manufacturing footprint that has supported registrations and exports into multiple overseas markets.